ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Pepperstone

Trade Now

Pepperstone
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P ASX 200
8,250.50
0.60%
S&P ASX All Technology
3,828.50
0.37%
Brent Oil
76.495
0.00%
US Dollar vs AUD
1.60929
0.05%
Bitcoin
97,864.00
-0.35%
Pepperstone
Advertisement
Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. UK
  5. LSE

  6. I-nexus Global Plc (INX) Share Price

I-nexus Global Plc

I-nexus Global Plc (INX)

IMCD NV
Intouch Insight Ltd
2.25
0.00
(0.00%)
Closed 06 January 3:30AM
Delayed by 15 minutes

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Premium

Key stats and details

Current Price
2.25
Bid
1.50
Offer
3.00
Volume
0.00
0.00 Day's Range 0.00
0.65 52 Week Range 5.50
Market Cap
665.361k
Previous Close
2.25
Open
-
Last Trade
(O)
Last Trade Time
Financial Volume
-
VWAP
-
Average Volume (3m)
227,886
Shares Outstanding
29,571,605
Dividend Yield
-
PE Ratio
-0.88
Earnings Per Share (EPS)
-0.03
Revenue
3.53M
Net Profit
-756k

About I-nexus Global Plc

Sector
Prepackaged Software
Industry
Prepackaged Software
Website
www.i-nexus.com
Headquarters
London, Gbr
Founded
-
I-nexus Global Plc is listed in the Prepackaged Software sector of the London Stock Exchange with ticker INX. The last closing price for I-nexus Global was 2.25p. Over the last year, I-nexus Global shares have traded in a share price range of 0.65p to 5.50p.

I-nexus Global currently has 29,571,605 shares in issue. The market capitalisation of I-nexus Global is £665,361.11 . I-nexus Global has a price to earnings ratio (PE ratio) of -0.88.

Ask ADVFN Intelligence (AI)

INX Latest News

More News

AIM Cancellation - i-nexus Global plc

AIM 27 December 2024   NOTICE   27/12/2024 - 07:00   NOTICE OF CANCELLATION OF ADMISSION TO TRADING ON AIM   At the request of the company the following securities have been cancelled from...

27 December 2024
RNS Regulatory News

i-nexus Global PLC Result of General Meeting

i-nexus Global PLC 13 December 2024   13 December 2024   i-nexus Global plc ("i-nexus", the "Company" or the "Group")   Result of General Meeting   Further to the announcement on 26 November...

14 December 2024
RNS Regulatory News

i-nexus Global plots AIM exit amid "weak share price performance"

i-nexus Global PLC proposed on Friday to cancel its shares from AIM trading and re-register as a private company. T ...

06 December 2024
Alliance News

i-nexus Global PLC Proposed Cancellation of Admission to Trading

i-nexus Global PLC 26 November 2024   THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION FOR THE PURPOSES OF ARTICLE 7 OF THE MARKET ABUSE REGULATION (EU) 596/2014 AS IT FORMS PART OF UK DOMESTIC...

26 November 2024
RNS Regulatory News

i-nexus Global PLC Extension of Redemption Date of CLNs

i-nexus Global PLC 28 October 2024   28 October 2024 i-nexus Global plc ("i-nexus", the "Company" or the "Group")   Extension of Redemption Date of Convertible Loan Notes   i-nexus Global...

28 October 2024
RNS Regulatory News

IN BRIEF: i-nexus Global inks three year contract in North America

C - Coventry, England-based software company - Signs a three-year contract with an unnamed "North American engineered ...

26 July 2024
Alliance News

i-nexus Global PLC Contract Win

i-nexus Global PLC 25 July 2024   RNS Reach 25 July 2024 i-nexus Global plc ("i-nexus", the "Company" or the "Group") Contract Win i-nexus secures new North American customer i-nexus Global...

25 July 2024
RNS Non-Regulatory

IN BRIEF: i-nexus Global remains positive as interim loss narrows

C - Coventry, England-based software company - Revenue in the six months ended March 31 comes in at GBP1.7 million, un ...

04 May 2024
Alliance News

i-nexus Global PLC Interim Results

i-nexus Global PLC 03 May 2024   3 May 2024 i-nexus Global plc ("i-nexus", the "Company" or the "Group") Interim Results i-nexus Global plc (AIM: INX), a leading provider of cloud-based...

03 May 2024
RNS Regulatory News

i-nexus Global PLC Result of AGM

i-nexus Global PLC 26 February 2024   26 February 2024 i-nexus Global plc ("i-nexus", the "Company" or the "Group")   Result of AGM   i-nexus Global plc (AIM: INX), a leading provider of...

27 February 2024
RNS Regulatory News
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1002.252.252.2500DE
40.528.57142857141.7531.151445611.6592291DE
12-0.9-28.57142857143.153.150.652278861.59922939DE
26-0.5-18.18181818182.755.50.651494592.40024444DE
52002.255.50.651024992.66461869DE
156-3.25-59.09090909095.59.10.651067214.33497336DE
260-14.25-86.363636363616.516.50.652011485.43477624DE

INX - Frequently Asked Questions (FAQ)

What is the current I-nexus Global share price?
The current share price of I-nexus Global is 2.25p
How many I-nexus Global shares are in issue?
I-nexus Global has 29,571,605 shares in issue
What is the market cap of I-nexus Global?
The market capitalisation of I-nexus Global is GBP 665.36k
What is the 1 year trading range for I-nexus Global share price?
I-nexus Global has traded in the range of 0.65p to 5.50p during the past year
What is the PE ratio of I-nexus Global?
The price to earnings ratio of I-nexus Global is -0.88
What is the cash to sales ratio of I-nexus Global?
The cash to sales ratio of I-nexus Global is 0.19
What is the reporting currency for I-nexus Global?
I-nexus Global reports financial results in GBP
What is the latest annual turnover for I-nexus Global?
The latest annual turnover of I-nexus Global is GBP 3.53M
What is the latest annual profit for I-nexus Global?
The latest annual profit of I-nexus Global is GBP -756k
What is the registered address of I-nexus Global?
The registered address for I-nexus Global is 27-28 EASTCASTLE STREET, LONDON, W1W 8DH
What is the I-nexus Global website address?
The website address for I-nexus Global is www.i-nexus.com
Which industry sector does I-nexus Global operate in?
I-nexus Global operates in the PREPACKAGED SOFTWARE sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
TCFTheracryf Plc
0.725p
(38.10%)
7.56M
NMTNeometals Ltd
3.50p
(27.27%)
346.81k
SCHOScholium Group Plc
44.00p
(25.71%)
30.65k
FABFusion Antibodies Plc
10.15p
(24.54%)
3.34M
PYXPyx Resources Limited
3.49p
(22.24%)
8.43k
TM1Technology Minerals Plc
0.125p
(-24.24%)
37.21M
QUIZQuiz Plc
0.70p
(-18.60%)
3.67M
SYMESupply@me Capital Plc
0.003p
(-17.81%)
168.35M
OBDOxford Biodynamics Plc
1.20p
(-14.29%)
827.83k
ZENZenith Energy Ltd.
5.25p
(-13.93%)
5.39M
TRPTower Resources Plc
0.0395p
(5.33%)
539.51M
CPXCap-xx Limited
0.1825p
(1.39%)
494M
NTVONativo Resources Plc
0.0019p
(0.00%)
320.16M
DGIDg Innovate Plc
0.0225p
(-13.46%)
208.21M
ENETEthernity Networks Ltd
0.1125p
(2.27%)
207.56M

Discussion

View Full Feed
Red Cloud Red Cloud 3 minutes ago
Thanks so much for your response

I'll look for the text of those Warrant Agreements
FNMA
fuagf fuagf 3 minutes ago
Flip flop artist Trump is a flip, and sadly will most likely be a flop as president again.

https://www.usnews.com/object/image/00000194-1e6c-d7ea-a1d5-5fee8e950000/20241231ednac-a.jpg?update-time=1735677640116&size=responsiveGallery
barnyarddog barnyarddog 3 minutes ago
. NRx Pharmaceuticals is led by executives who have held leadership roles at Lilly, Pfizer, and Novartis as well as major investment banking institutions.



https://www.linkedin.com/company/nrx-pharma/
NRXP
Debunkinator Debunkinator 3 minutes ago
Short sellers down $180.9B in 2024 mark-to-market losses as Wall Street soars
LMAO--$$$$ Weeeeeeeeeeeeeeeeeeeeeeeee
ASII
attilathehunt attilathehunt 3 minutes ago
Somewhere in Bethesda....


Ring-a-ding-a-ring...

LP: Hello, this is Linda.

RD: Good morning Linda. This is Rob( Rob Davis, CEO of Merck)...

LP: Oh, hi Rob! I was expecting your call as soon as we received approval from the MHRA.
DJT NWBO
JR30 JR30 3 minutes ago
Shorty still crying when the SP is doing well.
VERB
dstock07734 dstock07734 4 minutes ago
I thought about the same thing. The only difference is that in my version Merck is the one who does the BLA submission to FDA. Just like what happened to the Daiichi's ADC. Here is the trial with Merck as collaborator. In October 2023, Merck and Daiichi struck the deal on three ADCs including the pl
NWBO
GetSeriousOK GetSeriousOK 4 minutes ago
OTC is entering a golden age in 2024 - Chartmaster.
OTC is entering a golden age in 2023 - Chartmaster.
OTC is entering a golden age in 2022 - Chartmaster.
I'm a genius and a millionaire - Chartmaster.

You know what they call that guy on every other board, don't y
BIEL
Monksdream Monksdream 4 minutes ago
HUH! Who wants to bet AAPL doesn’t make another new high in 2025
https://investorshub.advfn.com/uimage/uploads/2025/1/5/fngepIMG_4473.gif
AAPL
Involuntary-Recluse Involuntary-Recluse 5 minutes ago
Lmao, if only it worked that way T 😂
zab zab 5 minutes ago
I remember the real estate deferral tax deduction. I know I did not say it correctly,  but there is nothing better than claiming tax deduction on losses or gains in the future,  and using it to shield income. 
Hopeforthefuture3 Hopeforthefuture3 7 minutes ago
Eagle, imo good comparison in your post. One other item is that Kazia with paxalisib is part of the gbm AGILE program. As part of this they do have a patient level data control group. The program has 5 companies testing 5 different treatments and 1 soc control group to use as comparison with patient
NWBO
Zorax Zorax 8 minutes ago
Stupid Gets what Stupid Dose

Kind of ironic isn't it, using the wrong word about stupidity? lmao.

But then again, this just shows the tower of stupidity of trolls. I'd say the first 78 floors are empty of intelligence and the final 22 floors are just pure evil.
TURCH TURCH 10 minutes ago
Im ready for your long term play find it 😁


Regards 
marcis marcis 11 minutes ago
Ok Orlando Taddeo and his management is lying

Got it

Next
RDAR
skitahoe skitahoe 11 minutes ago
Market Beats article on AVXL

https://www.marketbeat.com/originals/short-squeeze-target-anavex-life-sciences-gains-traction/

I don't think anyone here posted this, it's complementary, but they're also pushing other stocks if you follow their link, which I didn't. I beli
AVXL JPM
JamesF1 JamesF1 12 minutes ago
Nasrat said on the last conference call that Elite sold their entire quota of Adderall. We don’t know if/when they obtained more quota. If they lost some market share on Adderall that is why. Vyvanse sales will almost all be in the current quarter, so February’s numbers MIGHT not be as impressiv
ELTP
jcromeenes jcromeenes 12 minutes ago
Yet January 16 looks to the the "exciting" day 😀
FNMA
John Doe 2024 John Doe 2024 12 minutes ago
It's none of their business what you funded or not. We can agree or disagree and argue on here but that's nobody's business but yours what you sold or didn't sell or funded.
XERI
mineanddine mineanddine 12 minutes ago
Noting that HIRU is a confirmed scam 
HIRU
surfkast surfkast 13 minutes ago
Obviously you did not even read the website. SMH
HMBL
BDEZ BDEZ 13 minutes ago
Exactly, wonder if that can be overturned by Executive order?
Samuel J Samuel J 13 minutes ago
One more thing Mr. PROBLEM with the none stop Calandar, tell me one CEO that is in the OTC that communicates as much as Josh, with a ticket on NASDAQ and a few in the OTC? 

Name me one ☝️ 

Laughable!
AZRH
FOFreddie FOFreddie 14 minutes ago
HI Red Cloud - Take a look at the Warrant Agreement - personally I did not see an anti-dilution provision but not sure. You can access from the websites - I have previously posted them so perhaps others have access to the Agreements. It would seem that the biggest dilution risk comes with earli
DJT

Your Recent History

LSE
INX
I-nexus Global
BOV
NUTR3M
NUTRIPLANT ON
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Australia
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2025 ADVFN PLC - All Rights Reserved

Go Ad-Free

Subscribe to Ad free and enjoy an ad-free experience

No Ads

Try Now

Keep the Ads